Teladoc (TDOC) Stock Falls Amid Market Uptick: What Investors Need to Know

Teladoc (TDOC) ended the recent trading session at $8.48, demonstrating a -2.42% change from the preceding day's closing price. The stock fell short of the S&P 500, which registered a gain of 0.79% for the day. At the same time, the Dow added 0.26%, and the tech-heavy Nasdaq gained 1.52%.

Coming into today, shares of the telehealth services provider had gained 9.86% in the past month. In that same time, the Medical sector gained 7.53%, while the S&P 500 lost 1.82%.

The investment community will be closely monitoring the performance of Teladoc in its forthcoming earnings report. On that day, Teladoc is projected to report earnings of -$0.24 per share, which would represent a year-over-year decline of 26.32%. In the meantime, our current consensus estimate forecasts the revenue to be $614.69 million, indicating a 2.72% decline compared to the corresponding quarter of the prior year.

Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of -$0.92 per share and revenue of $2.51 billion. These totals would mark changes of +19.3% and -0.92%, respectively, from last year.

Investors should also note any recent changes to analyst estimates for Teladoc. These recent revisions tend to reflect the evolving nature of short-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.

Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.

The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed an unchanged state. Teladoc currently has a Zacks Rank of #3 (Hold).

The Medical Services industry is part of the Medical sector. Currently, this industry holds a Zacks Industry Rank of 89, positioning it in the top 37% of all 250+ industries.

The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.

Story Continues

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Teladoc Health, Inc. (TDOC) : Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

View Comments